Erica Pietroluongo

Naples, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications

Less Is More, But Me-Too Should Not Be the Strategy for Lung Cancer Treatment in 2026.

Less Is More, But Me-Too Should Not Be the Strategy for Lung Cancer Treatment in 2026.

Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: April 08, 2026

Analysis of Large Language Model Decision Making in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.

Analysis of Large Language Model Decision Making in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.

Journal: JCO clinical cancer informatics
Published: March 06, 2026

Redefining therapeutic horizons in thymic epithelial tumors: precision, combinations, and emerging biology.

Redefining therapeutic horizons in thymic epithelial tumors: precision, combinations, and emerging biology.

Journal: NPJ precision oncology
Published: November 28, 2025

Deep learning discriminates thymic epithelial tumors' histological subtypes using digital pathology.

Deep learning discriminates thymic epithelial tumors' histological subtypes using digital pathology.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 13, 2025

Thymic Neuroendocrine Tumors: Evolving Insights and Innovative Approaches.

Thymic Neuroendocrine Tumors: Evolving Insights and Innovative Approaches.

Journal: JTO clinical and research reports
Published: September 16, 2025

Circulating innate lymphoid cells and IL-18 as potential immune biomarkers in thymic tumors.

Circulating innate lymphoid cells and IL-18 as potential immune biomarkers in thymic tumors.

Journal: Frontiers in immunology
Published: September 15, 2025

Diagnosis and treatment of paragangliomas and pheochromocytomas: a survey from the Italian Association for Neuroendocrine Tumors.

Diagnosis and treatment of paragangliomas and pheochromocytomas: a survey from the Italian Association for Neuroendocrine Tumors.

Journal: Frontiers in endocrinology
Published: August 17, 2025

Impact of relative dose intensity of first-line platinum-based chemotherapy in patients with thymic epithelial tumors: a retrospective study.

Impact of relative dose intensity of first-line platinum-based chemotherapy in patients with thymic epithelial tumors: a retrospective study.

Journal: Therapeutic advances in medical oncology
Published: August 05, 2025

Immunopathological Profile of Patients with Thymic Epithelial Tumour and Good Syndrome in Advanced Stage.

Immunopathological Profile of Patients with Thymic Epithelial Tumour and Good Syndrome in Advanced Stage.

Journal: Journal of clinical immunology
Published: July 08, 2025

Management of Autoimmune Conditions Associated With Thymic Epithelial Tumors.

Management of Autoimmune Conditions Associated With Thymic Epithelial Tumors.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: May 16, 2025

When rarity meets thoracic cancers: a narrative review from ITMIG 2024.

When rarity meets thoracic cancers: a narrative review from ITMIG 2024.

Journal: Mediastinum (Hong Kong, China)
Published: April 15, 2025

Immune-related disorders in patients with Thymic Epithelial Tumors: from pathogenesis to tailored interventions.

Immune-related disorders in patients with Thymic Epithelial Tumors: from pathogenesis to tailored interventions.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 15, 2025
Showing 1-12 of 37

Last Updated: 09/26/2026